Zobrazeno 1 - 10
of 350
pro vyhledávání: '"Platenburg G"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kaltak M; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; ProQR Therapeutics, Leiden, The Netherlands., Blanco-Garavito R; Department of Ophthalmology, Intercommunal Hospital Center and Henri Mondor Hospital, Paris-Est Créteil University, Creteil, France., Molday LL; Department of Biochemistry and Molecular Biology, Department of Ophthalmology and Visual Sciences, Centre for Macular Research, University of British Columbia, Vancouver, BC, Canada., Dhaenens CM; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France., Souied EE; Department of Ophthalmology, Intercommunal Hospital Center and Henri Mondor Hospital, Paris-Est Créteil University, Creteil, France., Platenburg G; ProQR Therapeutics, Leiden, The Netherlands., Swildens J; ProQR Therapeutics, Leiden, The Netherlands., Molday RS; Department of Biochemistry and Molecular Biology, Department of Ophthalmology and Visual Sciences, Centre for Macular Research, University of British Columbia, Vancouver, BC, Canada., Cremers FPM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. frans.cremers@radboudumc.nl.
Publikováno v:
Journal of translational medicine [J Transl Med] 2023 Aug 16; Vol. 21 (1), pp. 546. Date of Electronic Publication: 2023 Aug 16.
Autor:
Kooij KL; Department of Translational Neuroscience, UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands; Altrecht Eating Disorders Rintveld, Zeist, the Netherlands. Electronic address: k.l.kooij@umcutrecht.nl., Luijendijk MCM; Department of Translational Neuroscience, UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands. Electronic address: M.c.m.luijendijk@umcutrecht.nl., Drost L; Department of Translational Neuroscience, UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands., Platenburg G; Progress Therapeutics BV, Voorschoten, the Netherlands., van Elburg A; Altrecht Eating Disorders Rintveld, Zeist, the Netherlands; Department of Clinical Psychology, Utrecht University, the Netherlands. Electronic address: a.van.elburg@altrecht.nl., Adan RAH; Department of Translational Neuroscience, UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands; Altrecht Eating Disorders Rintveld, Zeist, the Netherlands; Dept of Neuroscience and Physiology, Sahlgrenska academy, Univ of Gothenborg, Sweden. Electronic address: r.a.h.adan@umcutrecht.nl.
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2023 Jun; Vol. 71, pp. 65-74. Date of Electronic Publication: 2023 Apr 07.
Autor:
Kaltak M; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands.; Department of Human Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, the Netherlands.; Academic Alliance Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, and Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands., de Bruijn P; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Piccolo D; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK., Lee SE; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK., Dulla K; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Hoogenboezem T; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Beumer W; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Webster AR; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK.; Moorfields Eye Hospital, 162 City Road, EC1V 2PD London, UK., Collin RWJ; Department of Human Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, the Netherlands.; Academic Alliance Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, and Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands., Cheetham ME; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK., Platenburg G; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Swildens J; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Feb 18; Vol. 31, pp. 674-688. Date of Electronic Publication: 2023 Feb 18 (Print Publication: 2023).
Autor:
Adachi H; Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester Medical Center, Rochester, NY, USA., Pan Y; Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester Medical Center, Rochester, NY, USA., He X; Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester Medical Center, Rochester, NY, USA., Chen JL; Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester Medical Center, Rochester, NY, USA., Klein B; ProQR Therapeutics, Leiden, the Netherlands., Platenburg G; ProQR Therapeutics, Leiden, the Netherlands., Morais P; ProQR Therapeutics, Leiden, the Netherlands. Electronic address: pmorais@proqr.com., Boutz P; Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester Medical Center, Rochester, NY, USA; Center for Biomedical Informatics and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: paul_boutz@urmc.rochester.edu., Yu YT; Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: yitao_yu@urmc.rochester.edu.
Publikováno v:
Molecular cell [Mol Cell] 2023 Feb 16; Vol. 83 (4), pp. 637-651.e9. Date of Electronic Publication: 2023 Feb 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Russell SR; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA. steve-russell@uiowa.edu., Drack AV; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA., Cideciyan AV; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Jacobson SG; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Leroy BP; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.; Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium.; Division of Ophthalmology and Center for Cellular & Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Van Cauwenbergh C; Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium., Ho AC; Wills Eye Hospital/Mid Atlantic Retina, Philadelphia, PA, USA., Dumitrescu AV; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA., Han IC; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA., Martin M; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA., Pfeifer WL; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA., Sohn EH; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA., Walshire J; University of Iowa Institute for Vision Research, University of Iowa, Iowa City, IA, USA., Garafalo AV; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Krishnan AK; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Powers CA; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Sumaroka A; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Roman AJ; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Vanhonsebrouck E; Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium., Jones E; Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium., Nerinckx F; Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium., De Zaeytijd J; Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium., Collin RWJ; Department of Human Genetics and Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands., Hoyng C; Department of Ophthalmology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands., Adamson P; UCL Institute of Ophthalmology, London, UK., Cheetham ME; UCL Institute of Ophthalmology, London, UK., Schwartz MR; ProQR Therapeutics, Leiden, The Netherlands., den Hollander W; 3D-PharmXchange, Tilburg, The Netherlands., Asmus F; Oxular Limited, Magdalen Centre, Oxford, UK., Platenburg G; ProQR Therapeutics, Leiden, The Netherlands., Rodman D; Mineralys Therapeutics, Radnor, PA, USA., Girach A; ProQR Therapeutics, Leiden, The Netherlands.
Publikováno v:
Nature medicine [Nat Med] 2022 May; Vol. 28 (5), pp. 1014-1021. Date of Electronic Publication: 2022 Apr 04.
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
Autor:
Dulla K; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Slijkerman R; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., van Diepen HC; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Albert S; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Dona M; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Beumer W; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Turunen JJ; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Chan HL; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Schulkens IA; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Vorthoren L; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., den Besten C; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Buil L; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Schmidt I; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Miao J; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Venselaar H; Center for Molecular and Biomolecular Informatics, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Zang J; University of Zürich, Institute of Molecular Life Sciences, 8057 Zürich, Switzerland., Neuhauss SCF; University of Zürich, Institute of Molecular Life Sciences, 8057 Zürich, Switzerland., Peters T; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Broekman S; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Pennings R; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Kremer H; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Platenburg G; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Adamson P; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands; UCL, Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK., de Vrieze E; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., van Wijk E; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands. Electronic address: erwin.vanwyk@radboudumc.nl.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Aug 04; Vol. 29 (8), pp. 2441-2455. Date of Electronic Publication: 2021 Apr 23.
Autor:
Bornert O; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany., Hogervorst M; ProQR Therapeutics N.V., Leiden, The Netherlands., Nauroy P; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany., Bischof J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria., Swildens J; ProQR Therapeutics N.V., Leiden, The Netherlands., Athanasiou I; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany., Tufa SF; Micro-Imaging Center, Shriners Hospital for Children, Portland, Oregon, USA., Keene DR; Micro-Imaging Center, Shriners Hospital for Children, Portland, Oregon, USA., Kiritsi D; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany., Hainzl S; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria., Murauer EM; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria., Marinkovich MP; Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA; Dermatology, Veteran's Affairs Medical Center, Palo Alto, California, USA., Platenburg G; ProQR Therapeutics N.V., Leiden, The Netherlands., Hausser I; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Wally V; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria., Ritsema T; ProQR Therapeutics N.V., Leiden, The Netherlands., Koller U; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria., Haisma EM; ProQR Therapeutics N.V., Leiden, The Netherlands., Nyström A; Department of Dermatology, Medical Faculty, Medical Center - University of Freiburg, Freiburg, Germany. Electronic address: alexander.nystroem@uniklinik-freiburg.de.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2021 Apr; Vol. 141 (4), pp. 883-893.e6. Date of Electronic Publication: 2020 Sep 16.
Autor:
Beumer W; ProQR Therapeutics, Leiden, The Netherlands., Swildens J; ProQR Therapeutics, Leiden, The Netherlands., Leal T; Université Catholique de Louvain, Louvain Centre for Toxicology and Applied Pharmacology, Brussels, Belgium., Noel S; Université Catholique de Louvain, Louvain Centre for Toxicology and Applied Pharmacology, Brussels, Belgium., Anthonijsz H; ProQR Therapeutics, Leiden, The Netherlands., van der Horst G; ProQR Therapeutics, Leiden, The Netherlands., Kuiperij-Boersma H; ProQR Therapeutics, Leiden, The Netherlands., Potman M; ProQR Therapeutics, Leiden, The Netherlands., van Putten C; ProQR Therapeutics, Leiden, The Netherlands., Biasutto P; ProQR Therapeutics, Leiden, The Netherlands., Platenburg G; ProQR Therapeutics, Leiden, The Netherlands., de Jonge H; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Henig N; ProQR Therapeutics, Leiden, The Netherlands., Ritsema T; ProQR Therapeutics, Leiden, The Netherlands.
Publikováno v:
PloS one [PLoS One] 2019 Jun 28; Vol. 14 (6), pp. e0219182. Date of Electronic Publication: 2019 Jun 28 (Print Publication: 2019).